Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHome Reit Regulatory News (HOME)

Share Price Information for Home Reit (HOME)

Share Price is delayed by 15 minutes
Get Live Data
10.10    0.00 (0.00%)
Bid:
9.85
Ask:
10.70
Spread: 0.85 (8.629%)
Market Cap: £79.85m
HOME Live PriceLast checked at - London Stock Exchange

Intraday Home Reit Share Chart

Form 8.3 - J Sainsbury PLC

9 Aug 2016 15:11

RNS Number : 7116G
AllianzGI-Global Equity Business
09 August 2016
 

FORM 8.3

 

PUBLIC DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Full name of discloser:

Allianz Global Investors - Global Equity Business Unit

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

J Sainsbury Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

 

8 August 2016

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

 

Yes - Home Retail Group Plc

 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

 

 

Class of relevant security:

 

28 4/7p ordinary shares

(incl ADRs)

 

 

 

Interests

Short positions

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

20,612,341

1.07%

(2) Cash-settled derivatives:

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

220,000

0.01%

 

TOTAL:

20,612,341

1.07%

220,000

0.01%

 

 

 

 

 

 

All interests and all short positions should be disclosed.

 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

 

(b) Rights to subscribe for new securities (including directors' and other employee options)

 

Class of relevant security in relation to which subscription right exists:

Details, including nature of the rights concerned and relevant percentages:

 

 

 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

28 4/7p ordinary

Sale

12,739

2.3480 GBP

 

 

(b) Cash-settled derivative transactions

 

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

 

4. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

(c) Attachments

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

 

 

 

Date of disclosure:

09 August 2016

Contact name:

Govinder Bedi

Telephone number:

+44 (0) 20 3246 7137

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk

 

 

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

 

DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

 

 

1. KEY INFORMATION

 

Identity of person whose open positions are being disclosed:

Allianz Global Investors - Global Equity Business Unit

Name of offeror/offeree in relation to whose relevant securities the disclosure relates:

J Sainsbury Plc

 

 

 

 

 

 

 

 

2. OPTIONS AND DERIVATIVES

 

Class of relevant security

Product description e.g. call option

Written or purchased

Number of securities to which option or derivative relates

Exercise price per unit

Type

e.g.American, European etc.

Expiry date

28 4/7p ordinary

Put option

Purchased

220,000

270

American

16 Sep 2016

 

 

 

 

3. AGREEMENTS TO PURCHASE OR SELL ETC.

 

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to contracts for differences ("CFDs") or spread bets.

 

The currency of all prices and other monetary amounts should be stated.

 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RETAKCDKQBKDPFK
Date   Source Headline
5th Dec 202412:11 pmRNSResult of General Meeting
4th Dec 202412:01 pmRNSResponse to announcement from Southey Capital Ltd
28th Nov 20247:00 amRNSRepayment of Debt
18th Nov 20247:00 amRNSChange of Registered Office
8th Nov 202412:37 pmRNSPosting of Notice of General Meeting
23rd Oct 20247:00 amRNSProperty Sales and Debt Repayment Update
14th Oct 20247:00 amRNSMonthly Update
11th Oct 20247:00 amRNSAnnual Financial Report
30th Sep 20247:00 amRNSProperty Sales
16th Sep 20242:56 pmRNSResult of General Meeting
5th Sep 20247:00 amRNSMonthly Update
30th Aug 20247:00 amRNSProperty Sales
23rd Aug 20247:00 amRNSPosting of Circular
14th Aug 20247:00 amRNSSurrender of leases
8th Aug 20247:00 amRNSTenant Update
5th Aug 20247:00 amRNSMonthly Update
2nd Aug 20247:00 amRNSProperty Sales
16th Jul 20247:00 amRNSProposed managed wind-down strategy
3rd Jul 20247:00 amRNSMonthly Update
28th Jun 20247:00 amRNSUpdate to Publication of Annual & Interim Reports
21st Jun 20247:00 amRNSProperty Sales
17th Jun 20247:00 amRNSUpdate on Re-financing
7th Jun 20247:00 amRNSDirectorate Change
5th Jun 20247:00 amRNSMonthly Update
4th Jun 20247:00 amRNSTenant update
29th May 20247:00 amRNSAgreement secured for surrender of leases
10th May 20247:00 amRNSProperty Sales
7th May 20247:00 amRNSMonthly Update
22nd Apr 20249:00 amRNSNotice of retail shareholder presentation
19th Apr 20247:00 amRNSProperty Sales
18th Apr 20247:00 amRNSUpdate on Potential Litigation
4th Apr 20247:00 amRNSMonthly Update
2nd Apr 20243:00 pmRNSDirectorate Change
28th Mar 20247:00 amRNSProperty Sales
5th Mar 20247:00 amRNSMonthly Update
29th Feb 20241:39 pmRNSResult of AGM
15th Feb 20247:00 amRNSProperty Sales
13th Feb 202411:00 amRNSNotification of Investigation by the FCA
5th Feb 20247:00 amRNSMonthly Update
1st Feb 202411:00 amRNSNotice of AGM
24th Jan 20247:00 amRNSProperty Sales
18th Jan 20247:00 amRNSDirectorate Change
16th Jan 20241:33 pmRNSHolding(s) in Company
15th Jan 20244:12 pmRNSHolding(s) in Company
15th Jan 20249:00 amRNSNotice of Retail Shareholder Presentation
8th Jan 20247:00 amRNSMonthly Update
20th Dec 20237:01 amRNSProperty Sales
20th Dec 20237:00 amRNSProperty Valuation and Portfolio Update
5th Dec 20237:00 amRNSMonthly Update
28th Nov 20237:00 amRNSSurrender of leases

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.